SAVE Moms and Babies Act of 2025

This bill would block the FDA from approving any new drugs used to end a pregnancy and would stop or block new research exemptions for those drugs. It also adds stricter rules for drugs that are already approved, like making them prescription-only and limiting their use to the first 70 days of pregnancy .

For drugs already on the market, the bill requires in-person dosing by the prescriber at a clinic, doctor’s office, or hospital—not at a pharmacy or by mail. Prescribers must have special certification and be able to confirm how far along the pregnancy is, check for ectopic pregnancy, and provide or arrange emergency care, including surgery and blood transfusions, if needed. It also requires broad reporting of complications by prescribers, manufacturers, and other health workers, and says states and the federal government may add more restrictions. Ongoing research exemptions would be canceled three years after the law takes effect if they would violate these new limits .

Key points

• Who is affected: Patients seeking abortion pills; doctors and other prescribers; pharmacies; drug makers; researchers.
• What changes: No approval of new abortion drugs; tighter rules on existing ones (in-person dosing by the prescriber, up to 70 days of pregnancy, special certifications, required complication reporting).
• When: Most changes take effect upon enactment; certain existing research exemptions end three years after enactment if they conflict with the new rules.